Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?

E.M. Mukherjee; E.J. Phillips

doi:10.1016/j.anai.2022.06.025

Back

Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?

Journal article

Peer reviewed

Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?

E.M. Mukherjee and E.J. Phillips

Annals of Allergy, Asthma & Immunology, Vol.129(3), pp.269-270

2022

DOI: https://doi.org/10.1016/j.anai.2022.06.025

Abstract

Stevens-Johnson syndrome and toxic epidermal necrolysis (SJS/TEN) is the most severe of cutaneous drug reactions, with a mortality rate of up to 50% in patients who are immunocompromised and in older patients...

Details

Title: Where to place etanercept and combination treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis?
Authors/Creators: E.M. Mukherjee (Author/Creator) - Vanderbilt University Medical Center
E.J. Phillips (Author/Creator) - Vanderbilt University Medical Center
Publication Details: Annals of Allergy, Asthma & Immunology, Vol.129(3), pp.269-270
Publisher: Elsevier Inc.
Identifiers: 991005541997607891
Copyright: © 2022 American College of Allergy, Asthma & Immunology
Murdoch Affiliation: Institute for Immunology and Infectious Diseases
Language: English
Resource Type: Journal article

UN Sustainable Development Goals (SDGs)

This output has contributed to the advancement of the following goals:

Source: InCites

Metrics

53 Record Views

4 Times Cited - Web of Science

InCites Highlights

These are selected metrics from InCites Benchmarking & Analytics tool, related to this output

Collaboration types: Domestic collaboration; International collaboration
Citation topics: 1 Clinical & Life Sciences; 1.265 Dermatology - Skin Allergies; 1.265.1140 Drug Hypersensitivity
Web Of Science research areas: Allergy; Immunology
ESI research areas: Immunology